Related Experiment Video

Updated: Jul 4, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk

Valerie Gossye1, Guy Haegeman, Karolien De Bosscher

  • 1Laboratory for Eukaryotic Gene Expression and Signal Transduction, Department of Molecular Biology, Ghent University, K.L. Ledeganckstraat 35, 9000 Gent, Belgium.

Frontiers in Bioscience : a Journal and Virtual Library
|May 30, 2008
PubMed

Insights

Nuclear receptors can modulate NF-kappaB signaling, a key factor in cancer development. This review explores their therapeutic potential and strategies to enhance specificity, aiming to improve cancer treatment by targeting inflammation and cancer pathways.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Nuclear factor-kappa B (NF-kappaB) is crucial in tumor development and links inflammation to cancer.
  • Many cancer drugs target NF-kappaB activity for their anti-tumor effects.
  • Nuclear receptors show potential in modulating NF-kappaB, but broad actions cause side effects.

Purpose of the Study:

  • To explore molecular mechanisms of nuclear receptor interference with NF-kappaB signaling.
  • To discuss therapeutic implications of nuclear receptor and NF-kappaB cross-coupling.
  • To review strategies for improving specificity of nuclear receptor modulators.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of therapeutic implications of cross-coupling.
  • Review of current and future strategies for specificity.

Main Results:

  • Nuclear receptors can modulate NF-kappaB signaling pathways.
  • Cross-coupling offers therapeutic potential but requires specificity enhancement.
  • Various strategies are being explored to improve modulator specificity.

Conclusions:

  • Targeting the interplay between nuclear receptors and NF-kappaB is a promising therapeutic strategy for cancer.
  • Improving the specificity of nuclear receptor modulators is essential to minimize side effects.
  • Further research into these mechanisms and strategies holds significant therapeutic promise.

More Related Videos

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...